ACSL1 and ACSL5 have prognostic significance in gliomas, influencing tumor immunity and immune cell migration, thereby providing valuable insights into low-grade glioma (LGG) prognosis and potential therapeutic targets [141]. The gene discussed is ACSL1; the disease is neoplasm.